Chinese Lung Cancer Research Fund

The Chinese Lung Cancer Research Fund (CLCRF) is a prominent non-profit research organization based in Hong Kong, dedicated to advancing the diagnosis and treatment of lung cancer. Founded in 2004 by the world-renowned oncologist Professor Tony Mok, the fund serves as a critical hub for clinical research and academic exchange in the Asia-Pacific region. CLCRF primarily supports and coordinates multi-center clinical trials evaluating targeted therapies and immunotherapies, particularly those addressing genetic mutations prevalent in Asian populations, such as EGFR. Beyond research, the organization is dedicated to medical education and public awareness initiatives to combat the high incidence of lung cancer in the region.